These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 29735309

  • 1. The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.
    Pastor-Arroyo EM, Gehring N, Krudewig C, Costantino S, Bettoni C, Knöpfel T, Sabrautzki S, Lorenz-Depiereux B, Pastor J, Strom TM, Hrabě de Angelis M, Camici GG, Paneni F, Wagner CA, Rubio-Aliaga I.
    Kidney Int; 2018 Jul; 94(1):49-59. PubMed ID: 29735309
    [Abstract] [Full Text] [Related]

  • 2. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S, Austin AM, Gray AK, Econs MJ.
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [Abstract] [Full Text] [Related]

  • 3. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD.
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [Abstract] [Full Text] [Related]

  • 4. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
    Liu ES, Thoonen R, Petit E, Yu B, Buys ES, Scherrer-Crosbie M, Demay MB.
    Endocrinology; 2018 May 01; 159(5):2165-2172. PubMed ID: 29635291
    [Abstract] [Full Text] [Related]

  • 5. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.
    Ichikawa S, Gray AK, Bikorimana E, Econs MJ.
    Calcif Tissue Int; 2013 Aug 01; 93(2):155-62. PubMed ID: 23700148
    [Abstract] [Full Text] [Related]

  • 6. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M, Große Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D.
    Nephrol Dial Transplant; 2016 Jul 01; 31(7):1088-99. PubMed ID: 26681731
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
    Martin A, David V, Li H, Dai B, Feng JQ, Quarles LD.
    Mol Endocrinol; 2012 Nov 01; 26(11):1883-95. PubMed ID: 22930691
    [Abstract] [Full Text] [Related]

  • 8. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.
    Uchihashi K, Nakatani T, Goetz R, Mohammadi M, He X, Razzaque MS.
    Contrib Nephrol; 2013 Nov 01; 180():124-37. PubMed ID: 23652555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
    Razali NN, Hwu TT, Thilakavathy K.
    J Pediatr Endocrinol Metab; 2015 Sep 01; 28(9-10):1009-17. PubMed ID: 25894638
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
    Kinoshita Y, Saito T, Shimizu Y, Hori M, Taguchi M, Igarashi T, Fukumoto S, Fujita T.
    Eur J Endocrinol; 2012 Aug 01; 167(2):165-72. PubMed ID: 22577109
    [Abstract] [Full Text] [Related]

  • 12. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD.
    FASEB J; 2011 Aug 01; 25(8):2551-62. PubMed ID: 21507898
    [Abstract] [Full Text] [Related]

  • 13. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
    Igaki JM, Yamada M, Yamazaki Y, Koto S, Izawa M, Ariyasu D, Suzuki E, Hasegawa H, Hasegawa Y.
    Endocr J; 2011 Aug 01; 58(8):647-55. PubMed ID: 21597229
    [Abstract] [Full Text] [Related]

  • 14. A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice.
    Ichikawa S, Gerard-O'Riley RL, Acton D, McQueen AK, Strobel IE, Witcher PC, Feng JQ, Econs MJ.
    Endocrinology; 2017 Mar 01; 158(3):470-476. PubMed ID: 28005411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
    David V, Martin A, Hedge AM, Drezner MK, Rowe PS.
    Am J Physiol Renal Physiol; 2011 Mar 01; 300(3):F783-91. PubMed ID: 21177780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause.
    Sawatsubashi S, Takashi Y, Endo I, Kondo T, Abe M, Matsumoto T, Fukumoto S.
    Bone; 2024 May 01; 182():117057. PubMed ID: 38412893
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.